Advertisement

Loading...

North Bud Farms Inc.

NBUD.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.05
$0.00(0.00%)
Canadian Market opens in 16h 33m

North Bud Farms Inc. Fundamental Analysis

North Bud Farms Inc. (NBUD.CN) shows weak financial fundamentals with a PE ratio of -1.54, profit margin of 0.00%, and ROE of -27.00%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position144.57%
PEG Ratio-0.02
Current Ratio4.48

Areas of Concern

ROE-27.00%
Operating Margin0.00%
We analyze NBUD.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 3.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
3.7/100

We analyze NBUD.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

NBUD.CN struggles to generate sufficient returns from assets.

ROA > 10%
-23.46%

Valuation Score

Excellent

NBUD.CN trades at attractive valuation levels.

PE < 25
-1.54
PEG Ratio < 2
-0.02

Growth Score

Weak

NBUD.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

NBUD.CN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
4.48

Profitability Score

Weak

NBUD.CN struggles to sustain strong margins.

ROE > 15%
-2700.24%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is NBUD.CN Expensive or Cheap?

P/E Ratio

NBUD.CN trades at -1.54 times earnings. This suggests potential undervaluation.

-1.54

PEG Ratio

When adjusting for growth, NBUD.CN's PEG of -0.02 indicates potential undervaluation.

-0.02

Price to Book

The market values North Bud Farms Inc. at 0.42 times its book value. This may indicate undervaluation.

0.42

EV/EBITDA

Enterprise value stands at -3.96 times EBITDA. This is generally considered low.

-3.96

How Well Does NBUD.CN Make Money?

Net Profit Margin

For every $100 in sales, North Bud Farms Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-27.00 in profit for every $100 of shareholder equity.

-27.00%

ROA

North Bud Farms Inc. generates $-23.46 in profit for every $100 in assets, demonstrating efficient asset deployment.

-23.46%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

NBUD.CN converts -41.00% of its market value into free cash.

-41.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.54

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.42

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.48

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.27

vs 25 benchmark

ROA

Return on assets percentage

-0.23

vs 25 benchmark

ROCE

Return on capital employed

-0.27

vs 25 benchmark

How NBUD.CN Stacks Against Its Sector Peers

MetricNBUD.CN ValueSector AveragePerformance
P/E Ratio-1.5427.91 Better (Cheaper)
ROE-27.00%687.00% Weak
Net Margin0.00%-45285.00% (disorted) Weak
Debt/Equity0.000.33 Strong (Low Leverage)
Current Ratio4.482795.76 Strong Liquidity
ROA-23.46%-13557.00% (disorted) Weak

NBUD.CN outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews North Bud Farms Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ